What question did this study set out to answer?

To explore advances in combined medical and surgical therapies for improving outcomes in resectable non-small cell lung cancer (NSCLC).

March 21, 2026Respirology

Recent Advances in Combined Medical and Surgical Therapy for Resectable NSCLC

View Full Paper

Ask AI

Bookmark

Authors

ABAdithya Balasubramanian JGJames GengPeter MacCallum Cancer Centre CWCatherine S. WilliamsPeter MacCallum Cancer Centre

Discussion

Member takes

Implication

This review discusses combined medical and surgical therapies that improve outcomes in resectable non-small cell lung cancer, indicating new treatment strategies are effective.

Key Points

To explore advances in combined medical and surgical therapies for improving outcomes in resectable non-small cell lung cancer (NSCLC).
Review of clinical evidence regarding systemic therapies in perioperative management of NSCLC
Analysis of tyrosine kinase inhibitors and immune checkpoint inhibitors
Discussion of biomarker-driven and multimodal treatment approaches
Tyrosine kinase inhibitors show significant survival improvements in molecularly defined resectable NSCLC
Immune checkpoint inhibitors improve pathological responses and survival in the perioperative setting
Emerging strategies aim to reduce relapse risk while minimizing overtreatment

Cite This Study

Balasubramanian et al. (2026) studied this question.

synapsesocial.com/papers/69be35f96e48c4981c67496e https://doi.org/10.1002/resp.70238

View Full Paper

Ask AI

Bookmark

Implication

This review discusses combined medical and surgical therapies that improve outcomes in resectable non-small cell lung cancer, indicating new treatment strategies are effective.

Recent Advances in Combined Medical and Surgical Therapy for Resectable NSCLC

Discussion

Member takes

Implication

Key Points

Cite This Study

Recent Advances in Combined Medical and Surgical Therapy for Resectable NSCLC

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider